Heartseed(ハートシード)株式会社 | Heartseed Inc. - iPS細胞による心臓の再生医療
https://heartseed.jp/The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
External timestamp
The evidence pack includes the third-party timestamp files.
Heartseed(ハートシード)株式会社 | Heartseed Inc. - iPS細胞による心臓の再生医療
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page is the official website of Heartseed Inc., a company developing cardiac regenerative medicine using iPS cells. The company's lead pipeline, HS-001, involves transplanting regenerated cardiac muscle derived from allogeneic iPS cells into the myocardium to restore contractile function in weakened hearts. It targets heart failure caused by left ventricular systolic dysfunction, a leading global cause of death. Heartseed pursues pioneering science to develop safe and effective next-generation regenerative therapies while prioritizing patient needs, aiming to revolutionize treatment for intractable diseases.
